Filter
666
Filtered Results: 666
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
62
New Publications
203
Language
Document type
No document type
346
Studies & Reports
120
Guidelines
96
Manuals
40
Strategic & Response Plan
40
Training Material
9
Fact sheets
9
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
35
Global
34
Kenya
31
Ethiopia
27
Uganda
16
South Africa
14
Western and Central Europe
13
Nepal
11
Tanzania
11
Liberia
11
Sierra Leone
10
Nigeria
10
Philippines
10
Namibia
9
Zambia
9
Ghana
8
Rwanda
8
Ukraine
7
Africa
7
Bangladesh
7
Myanmar / Burma
7
Zimbabwe
6
Indonesia
6
Syria
5
South Sudan
5
Lesotho
4
Malawi
4
Cambodia
4
Congo, Democratic Republic of
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Cameroon
3
Senegal
3
West and Central Africa
3
South–East Asia Region
3
Eswatini/ Swaziland
3
Thailand
2
Fiji
2
Laos
2
Burkina Faso
2
Mozambique
2
Asia
2
Latin America and the Carribbean
2
Jordan
2
East and Southern Africa
2
Vietnam
2
Botswana
2
Pakistan
2
Timor Leste/ East Timor
1
Australia
1
Benin
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Guinea
1
USA
1
Haiti
1
Lithuania
1
Middle East and North Africa
1
Belgium
1
United Kingdom
1
Southern Africa
1
Lebanon
1
Brazil
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
277
Clinical Guidelines
38
Key Resources
35
Public Health
32
Women & Child Health
21
Capacity Building
9
Pharmacy & Technologies
9
Toolboxes
Pharmacy
65
AMR
59
COVID-19
32
Mental Health
29
HIV
29
Planetary Health
28
TB
27
NTDs
25
Rapid Response
18
NCDs
17
Conflict
13
Caregiver
11
Health Financing Toolbox
11
Ebola
9
Global Health Education
9
Specific Hazards
6
Disability
5
Refugee
3
Natural Hazards
3
Social Ethics
2
Health Financing
2
South Sudan
1
Zika
1
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Assessment Report
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. Cervical cancer is the
second most common cancer among women in South Africa, after breast cancer. Due
to limited access to prevention, early dia...
